<DOC>
	<DOCNO>NCT01639560</DOCNO>
	<brief_summary>The purpose study determine varenicline effective treating tobacco dependence adult smoke 5-10 cigarette per day .</brief_summary>
	<brief_title>Varenicline Light Smokers</brief_title>
	<detailed_description>Nearly 50 % U.S. cigarette smoker smoke ≤ 10 cigarette per day ( CPD ) consider `` light smoker . '' Most light smoker either maintain chronic light smoke habit increase level smoking lifetime . Importantly , light smoker risk adverse health consequence increase all-cause mortality . While multiple factor reinforcement behavior , diminish autonomy , economic constraint tobacco control policy influence light smoking , nicotine dependence appear particularly important 5 10 CPD smoker . Despite high prevalence light smoking increase healthcare burden , study evaluate efficacy pharmacotherapy group smoker . Varenicline , target symptoms nicotine dependence , show increase smoking abstinence rate moderate heavy smoker ( ≥ 10 cigarette per day ) . However , varenicline evaluate subject smoke &lt; 10 CPD . In current proposal investigate efficacy varenicline smoking cessation 5 10 CPD light smoker wish quit . This study conduct double-blind , placebo-controlled , randomized clinical trial Mayo Clinic , enrol 224 eligible participant smoke 5 10 CPD . Participants receive behavior therapy either varenicline placebo 12 week follow 26 week . We determine varenicline increase smoke abstinence light smoker end-of-treatment 26 week compare placebo .</detailed_description>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . Subjects must ≥ 18 year age ; 2. smoke 5 10 CPD least 6 month ; 3. express interest quit smoking ; 4. indicate ability complete study visit ; 5. provide write informed consent participate study . 6 . Subject female subject nonchildbearing potential female subject childbearing potential use contraceptive negative pregnancy test result ; 7 . Subject good health determine investigator ; 8 . Subject ability participate fully aspects study keep scheduled appointment . 1 . An active medical condition unstable angina , myocardial infarction , coronary angioplasty within past 3 month untreated cardiac dysrhythmia ; 2 . History renal failure ; 3 . Cancer [ exclude nonmelanoma skin cancer ] remission ; 4 . Psychosis bipolar disorder ; 5 . Current unstable untreated moderate severe depression assess CESD ; 6. , define CSSRS ( ColumbiaSuicide Severity Rating Scale ) , current nonspecific suicidal thought , lifetime history suicidal attempt ( define `` potentially selfinjurious act commit least wish die , result act . `` ) ; 7 . Substance dependence nicotine , define : . Patient recent history ( past month ) heavy alcohol consumption define NIAAA : . Men : More 4 drink day 14 per week ii . Women : More 3 drink day 7 per week . b . Use cocaine , heroin , club drug ( i.e. , MDMA/ '' ecstasy '' ) , methamphetamine , hallucinogen ( e.g. , LSD ) time past month . c. Use marijuana weekly basis past month 8 . An allergy varenicline ; 9 . Current use behavioral pharmacologic tobacco dependence treatment unwilling unable discontinue use ; 10 . Another member household already participate study ; 11 . Current treatment another investigational drug ( within 30 day study entry ) . 12 . Has unstable medical condition ; 13 . Subject untreated hypertension baseline systolic blood pressure &gt; 180 diastolic &gt; 100 ; 14 . Women childbearing potential , pregnant , lactate likely become pregnant trial unwilling use acceptable form contraception medication phase also exclude . All female subject childbearing potential must negative pregnancy test must agree use approve contraception participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>smoking</keyword>
	<keyword>tobacco dependence</keyword>
	<keyword>nicotine dependence</keyword>
</DOC>